Dashboard
Manage Tickers

NERVMinerva Neurosciences, Inc.

Nasdaq minervaneurosciences.com


$ 2.63 $ 0.02 (0.77 %)    

Friday, 06-Sep-2024 14:02:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 2.61
$ 2.73 x 250
-- x --
-- - --
$ 2.26 - $ 13.49
3,910
na
18.25M
$ 0.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-01-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-08-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-02-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-08-2021 12-31-2020 10-K
16 11-02-2020 09-30-2020 10-Q
17 08-03-2020 06-30-2020 10-Q
18 05-04-2020 03-31-2020 10-Q
19 03-09-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-05-2019 06-30-2019 10-Q
22 05-06-2019 03-31-2019 10-Q
23 03-12-2019 12-31-2018 10-K
24 11-05-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 03-12-2018 12-31-2017 10-K
28 11-06-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 03-13-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-03-2016 03-31-2016 10-Q
35 03-14-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-26-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-neutral-on-minerva-neurosciences-lowers-price-target-to-5
HC Wainwright & Co. Maintains Neutral on M...
08/07/2024 20:21:42

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

minerva-neurosciences-q2-2024-gaap-eps-109-misses-073-estimate-cash-cash-equivalents-and-restricted-cash-at-june-30-2024-were-approximately-31m
Minerva Neurosciences Q2 2024 GAAP EPS $(1...
08/06/2024 11:43:05

hc-wainwright--co-maintains-neutral-on-minerva-neurosciences-lowers-price-target-to-7
HC Wainwright & Co. Maintains Neutral on M...
05/02/2024 17:31:53

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

minerva-neurosciences-q1-2024-gaap-eps-113-beats-120-estimate-cash-cash-equivalents-and-restricted-cash-of-349m
Minerva Neurosciences Q1 2024 GAAP EPS $(1...
05/01/2024 12:16:52

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(1.13) per share which beat the analyst consensus estimate of...

minerva-neurosciences-on-april-10-got-notice-from-nasdaq-that-company-was-not-in-compliance-with-nasdaqs-listing-rule
Minerva Neurosciences On April 10, Got Not...
04/12/2024 20:15:04

-SEC Filing

dow-dips-over-100-points-jm-smucker-posts-upbeat-earnings
Dow Dips Over 100 Points; J.M. Smucker Pos...
02/27/2024 19:32:26

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow ...

why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Helix Energy Solutions Shares Are Trad...
02/27/2024 18:18:56

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

regulatory-setback-for-minerva-neurosciences-schizophrenia-treatment-candidate-fda-asks-for-more-data
Regulatory Setback For Minerva Neuroscienc...
02/27/2024 17:53:40

Minerva Neurosciences faces FDA challenges for roluperidone in schizophrenia treatment. Understand the clinical deficiencies an...

hc-wainwright--co-reiterates-neutral-on-minerva-neurosciences-maintains-11-price-target
HC Wainwright & Co. Reiterates Neutral on ...
02/27/2024 17:35:33

HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $11...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
02/27/2024 17:31:10

crude-oil-gains-1-macys-plans-to-close-150-stores
Crude Oil Gains 1%; Macy's Plans To Close ...
02/27/2024 17:24:14

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded...

nasdaq-rises-50-points-lowes-earnings-top-views
Nasdaq Rises 50 Points; Lowe's Earnings To...
02/27/2024 14:42:28

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market ope...

minerva-neurosciences-shares-resume-trade
Minerva Neurosciences Shares Resume Trade
02/27/2024 14:40:37

minerva-neurosciences-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--582
Minerva Neurosciences Shares Halted On Cir...
02/27/2024 14:36:42

trading-halt-halt-status-updated-at-82500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:25:...
02/27/2024 13:25:06

minerva-neurosciences-receives-complete-response-letter-from-fda-for-new-drug-application-for-roluperidone-for-treatment-of-negative-symptoms-in-patients-with-schizophrenia-due-to-clinical-deficiencies
Minerva Neurosciences Receives Complete Re...
02/27/2024 13:09:55

In the CRL, the FDA cited the following clinical deficiencies:Although one study (MIN-101C03) demonstrated statistical signific...

trading-halt-halted-at-75500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:55:00 a.m. ET - ...
02/27/2024 12:55:04

minerva-neurosciences-q4-earnings-insights
Minerva Neurosciences: Q4 Earnings Insights
02/22/2024 13:20:14

minerva-neurosciences-q4-eps-119-misses-088-estimate-cash-cash-equivalents-and-restricted-cash-were-approximately-41m
Minerva Neurosciences Q4 EPS $(1.19) Misse...
02/22/2024 12:24:21

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate ...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
02/08/2024 17:31:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION